About Index Trending news
Analyze
Pricing
M3 Biotechnology

M3 Biotechnology

Work at M3 Biotechnology? Add yourself to this profile

M3 Biotechnology

M3 is a biopharmaceutical company focused on development of therapeutics to address Alzheimer's, Parkinson's and Neurodegeneration.
Edit Profile
More info

Elsewhere

Contributors to this profile

Also headquartered in Seattle

Amazon Amazon GeekWire GeekWire Zillow Zillow Starbucks Starbucks Redfin Redfin Tableau Tableau Seattle Seattle Wagon Wagon Startup Weekend Startup Weekend Bungie Bungie

Companies in the same industry

MassChallenge MassChallenge Syros Pharmaceuticals Syros Pharmaceuticals Exco InTouch Exco InTouch Wakati Wakati Clinipace Worldwide Clinipace Worldwide Transcriptic Transcriptic ORRECO ORRECO Cardax Cardax Ginkgo Bioworks Ginkgo Bioworks Fiberstar Inc. Fiberstar Inc.

Alexa global traffic share

Twitter followers

Terms of Service API Integrations Plans & Pricing
Built with ❤︎ by Datalicious ©2017
A daughter company of TNW.
Index.co is not affiliated with Index Ventures.

Overview

Funding 2
Add info
14 Apr 2017
$1,400,000
Undisclosed funding
Alzheimer’s Drug Discovery Foundation

M3 Biotechnology gets another $1.4M in funding, prepares to start clinical trials of leading drug candidate

GeekWire
11 Feb 2016
$10,000,000
Undisclosed
WRF Capital, Bruce Montgomery, W-Fund, +1
Added by

Seattle-drug startup M3Biotechnology closes $10 million funding round

GeekWire